BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Violi F, Basili S, Raparelli V, Chowdary P, Gatt A, Burroughs AK. Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction? J Hepatol 2011;55:1415-27. [PMID: 21718668 DOI: 10.1016/j.jhep.2011.06.008] [Cited by in Crossref: 121] [Cited by in F6Publishing: 126] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Begli NH, Freund C, Weiss K, Gotthardt D, Wannhoff A. Comparative proteomics reveals different protein expression in platelets in patients with alcoholic liver cirrhosis.. [DOI: 10.21203/rs.3.rs-1344377/v2] [Reference Citation Analysis]
2 La Mura V, Bitto N, Tripodi A. Rational hemostatic management in cirrhosis: from old paradigms to new clinical challenges. Expert Review of Hematology 2022. [DOI: 10.1080/17474086.2022.2144217] [Reference Citation Analysis]
3 Chen S, Tsai S, Lu H. Platelets as a Gauge of Liver Disease Kinetics? IJMS 2022;23:11460. [DOI: 10.3390/ijms231911460] [Reference Citation Analysis]
4 Satoh T, Takiguchi H, Uojima H, Kubo M, Tanaka C, Yokoyama F, Wada N, Miyazaki K, Hidaka H, Kusano C, Kuwana M, Horie R. B cell-activating factor is involved in thrombocytopenia in patients with liver cirrhosis. Ann Hematol 2022. [PMID: 36098792 DOI: 10.1007/s00277-022-04973-x] [Reference Citation Analysis]
5 Violi F, Pignatelli P, Castellani V, Carnevale R, Cammisotto V. Gut dysbiosis, endotoxemia and clotting activation: A dangerous trio for portal vein thrombosis in cirrhosis. Blood Rev 2022;:100998. [PMID: 35985881 DOI: 10.1016/j.blre.2022.100998] [Reference Citation Analysis]
6 Wang L, Guo X, Shao X, Xu X, Zheng K, Wang R, Chawla S, Basaranoglu M, Qi X. Association of endoscopic variceal treatment with portal venous system thrombosis in liver cirrhosis: a case–control study. Therap Adv Gastroenterol 2022;15:175628482210875. [DOI: 10.1177/17562848221087536] [Reference Citation Analysis]
7 van den Boom BP, Lisman T. Pathophysiology and management of bleeding and thrombosis in patients with liver disease. Int J Lab Hematol 2022. [PMID: 35446468 DOI: 10.1111/ijlh.13856] [Reference Citation Analysis]
8 Shettar SS, Vandyck K, Tanaka KA. Coagulation Management in End-Stage Liver Disease. Curr Anesthesiol Rep. [DOI: 10.1007/s40140-022-00524-2] [Reference Citation Analysis]
9 Islam R, Kundu S, Jha SB, Rivera AP, Flores Monar GV, Islam H, Puttagunta SM, Sange I. Cirrhosis and Coagulopathy: Mechanisms of Hemostasis Changes in Liver Failure and Their Management. Cureus. [DOI: 10.7759/cureus.23785] [Reference Citation Analysis]
10 Su F, Northup PG. Anticoagulants and Antiplatelet Agents in Cirrhosis. Pharmacotherapy for Liver Cirrhosis and Its Complications 2022. [DOI: 10.1007/978-981-19-2615-0_3] [Reference Citation Analysis]
11 Shropshire SB, Olver CS, Twedt DC, Jablonski Wennogle SA. Multiplate platelet aggregometry in dogs undergoing laparoscopic liver biopsy for diagnosis of chronic hepatopathy. J of Small Animal Practice. [DOI: 10.1111/jsap.13466] [Reference Citation Analysis]
12 Nguyen G, Lejeune M, Crichi B, Frere C. Hemostasis testing in patients with liver dysfunction: Advantages and caveats. World J Gastroenterol 2021; 27(42): 7285-7298 [PMID: 34876789 DOI: 10.3748/wjg.v27.i42.7285] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 McConnell MJ, Kondo R, Kawaguchi N, Iwakiri Y. Covid-19 and Liver Injury: Role of Inflammatory Endotheliopathy, Platelet Dysfunction, and Thrombosis. Hepatol Commun 2021. [PMID: 34658172 DOI: 10.1002/hep4.1843] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
14 Brodard J, Calzavarini S, Quarroz C, Berzigotti A, De Gottardi A, Angelillo-Scherrer A. Resistance to thrombomodulin correlates with liver stiffness in chronic liver disease a prospective single-center cohort study. Thromb Res 2021;207:40-9. [PMID: 34536665 DOI: 10.1016/j.thromres.2021.09.007] [Reference Citation Analysis]
15 Curakova Ristovska E. Endothelial Dysfunction and Systemic Inflammation in the Pathogenesis and Progression of Portal Hypertension. Portal Hypertension - Recent Advances 2021. [DOI: 10.5772/intechopen.96172] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Grassi G, Lenci I, Signorello A, Milana M, Baiocchi L. Gastrointestinal endoscopy in cirrhotic patient: Issues on the table. World J Gastrointest Endosc 2021; 13(7): 210-220 [PMID: 34326942 DOI: 10.4253/wjge.v13.i7.210] [Reference Citation Analysis]
17 McMurry HS, Jou J, Shatzel J. The hemostatic and thrombotic complications of liver disease. Eur J Haematol 2021. [PMID: 34258797 DOI: 10.1111/ejh.13688] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
18 Ballantine A, Martin D, Thakrar SV. The coagulopathy of liver disease: a shift in thinking. Br J Hosp Med (Lond) 2021;82:1-9. [PMID: 34191571 DOI: 10.12968/hmed.2021.0111] [Reference Citation Analysis]
19 Zanetto A, Senzolo M, Campello E, Bulato C, Gavasso S, Shalaby S, Gambato M, Vitale A, Cillo U, Farinati F, Russo FP, Simioni P, Burra P. Influence of Hepatocellular Carcinoma on Platelet Aggregation in Cirrhosis. Cancers (Basel) 2021;13:1150. [PMID: 33800224 DOI: 10.3390/cancers13051150] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
20 Alvaro D, Caporaso N, Giannini EG, Iacobellis A, Morelli M, Toniutto P, Violi F; PReBRiC (Procedure-Related Bleeding Risk in Cirrhosis) group. Procedure-related bleeding risk in patients with cirrhosis and severe thrombocytopenia. Eur J Clin Invest 2021;51:e13508. [PMID: 33539542 DOI: 10.1111/eci.13508] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
21 Northup PG, Garcia-Pagan JC, Garcia-Tsao G, Intagliata NM, Superina RA, Roberts LN, Lisman T, Valla DC. Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;73:366-413. [PMID: 33219529 DOI: 10.1002/hep.31646] [Cited by in Crossref: 123] [Cited by in F6Publishing: 134] [Article Influence: 123.0] [Reference Citation Analysis]
22 Görlinger K, Sakai T, Dirkmann D, Planinsic RM, Yassen K, Saner FH. Bleeding Related to Liver Transplant. Management of Bleeding Patients 2021. [DOI: 10.1007/978-3-030-56338-7_35] [Reference Citation Analysis]
23 Ciavarella A, Gnocchi D, Custodero C, Lenato GM, Fiore G, Sabbà C, Mazzocca A. Translational insight into prothrombotic state and hypercoagulation in nonalcoholic fatty liver disease. Thromb Res 2021;198:139-50. [PMID: 33340925 DOI: 10.1016/j.thromres.2020.12.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
24 Violi F, Loffredo L, Pastori D. Anticoagulation in patients with advanced liver disease: an open issue. Intern Emerg Med 2021;16:61-71. [PMID: 33073317 DOI: 10.1007/s11739-020-02526-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
25 Qu M, Zou X, Fang F, Wang S, Xu L, Zeng Q, Fan Z, Chen L, Yue W, Xie X, Pei X. Platelet-derived microparticles enhance megakaryocyte differentiation and platelet generation via miR-1915-3p. Nat Commun 2020;11:4964. [PMID: 33009394 DOI: 10.1038/s41467-020-18802-0] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 15.0] [Reference Citation Analysis]
26 Zanetto A, Rinder HM, Campello E, Saggiorato G, Deng Y, Ciarleglio M, Wilson FP, Senzolo M, Gavasso S, Bulato C, Simioni P, Garcia-Tsao G. Acute Kidney Injury in Decompensated Cirrhosis Is Associated With Both Hypo-coagulable and Hyper-coagulable Features. Hepatology 2020;72:1327-40. [PMID: 32614088 DOI: 10.1002/hep.31443] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 19.0] [Reference Citation Analysis]
27 Chen H, Chen X, Wang G. Platelets: A review of their function and effects in liver diseases. Liver Research 2020;4:129-35. [DOI: 10.1016/j.livres.2020.08.002] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Neuberger J, Patel J, Caldwell H, Davies S, Hebditch V, Hollywood C, Hubscher S, Karkhanis S, Lester W, Roslund N, West R, Wyatt JI, Heydtmann M. Guidelines on the use of liver biopsy in clinical practice from the British Society of Gastroenterology, the Royal College of Radiologists and the Royal College of Pathology. Gut 2020;69:1382-403. [PMID: 32467090 DOI: 10.1136/gutjnl-2020-321299] [Cited by in Crossref: 69] [Cited by in F6Publishing: 73] [Article Influence: 34.5] [Reference Citation Analysis]
29 Adam EH, Möhlmann M, Herrmann E, Schneider S, Zacharowski K, Zeuzem S, Weber CF, Weiler N. Assessment of hemostatic profile in patients with mild to advanced liver cirrhosis. World J Gastroenterol 2020; 26(17): 2097-2110 [PMID: 32536777 DOI: 10.3748/wjg.v26.i17.2097] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
30 van Dievoet MA, Eeckhoudt S, Stephenne X. Primary Hemostasis in Chronic Liver Disease and Cirrhosis: What Did We Learn over the Past Decade? Int J Mol Sci 2020;21:E3294. [PMID: 32384725 DOI: 10.3390/ijms21093294] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
31 Proietti M, Marzona I, Vannini T, Colacioppo P, Tettamanti M, Foresta A, Fortino I, Merlino L, Lip GYH, Roncaglioni MC. Impact of liver disease on oral anticoagulant prescription and major adverse events in patients with atrial fibrillation: analysis from a population-based cohort study. Eur Heart J Cardiovasc Pharmacother 2021;7:f84-92. [PMID: 32129845 DOI: 10.1093/ehjcvp/pvaa015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
32 Saner FH, Bezinover D. Assessment and management of coagulopathy in critically-ill patients with liver failure. Curr Opin Crit Care. 2019;25:179-186. [PMID: 30855324 DOI: 10.1097/mcc.0000000000000591] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
33 Lange NW, Salerno DM, Berger K, Cushing MM, Brown RS Jr. Management of Hepatic Coagulopathy in Bleeding and Nonbleeding Patients: An Evidence-Based Review. J Intensive Care Med 2021;36:524-41. [PMID: 32079443 DOI: 10.1177/0885066620903027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
34 Fritsma GA. Hemorrhagic disorders and laboratory assessment. Rodak's Hematology 2020. [DOI: 10.1016/b978-0-323-53045-3.00045-3] [Reference Citation Analysis]
35 Bleszynski MS, Kim PTW. Liver Transplantation. The Critically Ill Cirrhotic Patient 2020. [DOI: 10.1007/978-3-030-24490-3_14] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Donovan K, Stanworth S, Jairath V. The optimal use of blood components in the management of gastrointestinal bleeding. Best Practice & Research Clinical Gastroenterology 2019;42-43:101600. [DOI: 10.1016/j.bpg.2019.02.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
37 Brennan Y, Levade M, Ward CM. Acquired platelet function disorders. Thromb Res 2020;196:561-8. [PMID: 31229273 DOI: 10.1016/j.thromres.2019.06.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
38 Bonnet N, Paul J, Helleputte T, Veyckemans F, Pirotte T, Prégardien C, Eeckhoudt S, Hermans C, Detaille T, Clapuyt P, Menten R, Dumitriu D, Reding R, Scheers I, Varma S, Smets F, Sokal E, Stéphenne X. Novel insights into the assessment of risk of upper gastrointestinal bleeding in decompensated cirrhotic children. Pediatr Transplant 2019;23:e13390. [PMID: 30888111 DOI: 10.1111/petr.13390] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
39 Lisman T, Porte RJ. Understanding and Managing the Coagulopathy of Liver Disease. Consultative Hemostasis and Thrombosis 2019. [DOI: 10.1016/b978-0-323-46202-0.00036-4] [Reference Citation Analysis]
40 Reynolds JK, Bernard AC. Cirrhosis. Emergency General Surgery 2019. [DOI: 10.1007/978-3-319-96286-3_43] [Reference Citation Analysis]
41 Rizzo K, Vella K, Zammit D, Gatt P, Grima C, Inguanez MB, Gerada J, Ellul P, Vassallo M, Azzopardi N, Pocock J, Gatt A. Fibrinogen measurement in liver disease: validation of the functional fibrinogen thromboelastography assay and a novel mathematical predictive model. Blood Transfus 2019;17:237-46. [PMID: 30418134 DOI: 10.2450/2018.0105-18] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
42 Violi F, Talerico G, Basili S. A Closer Look at Platelet Count and Prediction of Bleeding in Cirrhotic Patients. American Journal of Gastroenterology 2018;113:1397-1398. [DOI: 10.1038/s41395-018-0191-8] [Reference Citation Analysis]
43 Eyraud D, Suner L, Dupont A, Bachelot-Loza C, Smadja DM, Helley D, Bertil S, Gostian O, Szymezak J, Loncar Y, Puybasset L, Lebray P, Vezinet C, Vaillant JC, Granger B, Gaussem P. Evolution of platelet functions in cirrhotic patients undergoing liver transplantation: A prospective exploration over a month. PLoS One 2018;13:e0200364. [PMID: 30071043 DOI: 10.1371/journal.pone.0200364] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
44 De Pietri L, Montalti R, Nicolini D, Troisi RI, Moccheggiani F, Vivarelli M. Perioperative thromboprophylaxis in liver transplant patients. World J Gastroenterol 2018;24:2931-48. [PMID: 30038462 DOI: 10.3748/wjg.v24.i27.2931] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
45 Drolz A, Ferlitsch A, Fuhrmann V. Management of Coagulopathy during Bleeding and Invasive Procedures in Patients with Liver Failure. Visc Med 2018;34:254-8. [PMID: 30345282 DOI: 10.1159/000491106] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
46 Loffredo L, Violi F. Thrombopoietin receptor agonists and risk of portal vein thrombosis in patients with liver disease and thrombocytopenia: A meta-analysis. Dig Liver Dis. 2019;51:24-27. [PMID: 29958825 DOI: 10.1016/j.dld.2018.06.005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
47 Fortea JI, Puente Á, Ezcurra I, Cuadrado A, Arias-Loste MT, Cabezas J, Llerena S, Iruzubieta P, Rodríguez-Lope C, Huelin P, Casafont F, Fábrega E, Crespo J. Management of haemostatic alterations and associated disorders in cirrhosis in Spain: A national survey. Dig Liver Dis 2019;51:95-103. [PMID: 29960901 DOI: 10.1016/j.dld.2018.06.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
48 Zuwala-Jagiello J, Pazgan-Simon M, Murawska-Cialowicz E, Simon K. Influence of Diabetes on Circulating Apoptotic Microparticles in Patients with Chronic Hepatitis C. In Vivo 2017;31:1027-34. [PMID: 28882977 DOI: 10.21873/invivo.11165] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
49 Medina JB, Andrade NS, de Paula Eduardo F, Bezinelli L, Franco JB, Gallottini M, Braz-Silva PH, Ortega KL. Bleeding during and after dental extractions in patients with liver cirrhosis. Int J Oral Maxillofac Surg 2018;47:1543-9. [PMID: 29705406 DOI: 10.1016/j.ijom.2018.04.007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
50 Breivik H, Norum H, Fenger-eriksen C, Alahuhta S, Vigfússon G, Thomas O, Lagerkranser M. Reducing risk of spinal haematoma from spinal and epidural pain procedures. Scandinavian Journal of Pain 2018;18:129-50. [DOI: 10.1515/sjpain-2018-0041] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
51 Intagliata NM, Caldwell SH. The Hemostatic and Hematopoietic System in Liver Disease. Zakim and Boyer's Hepatology 2018. [DOI: 10.1016/b978-0-323-37591-7.00019-7] [Reference Citation Analysis]
52 Basili S, Raparelli V, Napoleone L, Talerico G, Corazza GR, Perticone F, Sacerdoti D, Andriulli A, Licata A, Pietrangelo A, Picardi A, Raimondo G, Violi F; PRO-LIVER Collaborators. Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study. Am J Gastroenterol 2018;113:368-75. [PMID: 29257146 DOI: 10.1038/ajg.2017.457] [Cited by in Crossref: 54] [Cited by in F6Publishing: 57] [Article Influence: 10.8] [Reference Citation Analysis]
53 Blaine KP, Sakai T. Viscoelastic Monitoring to Guide Hemostatic Resuscitation in Liver Transplantation Surgery. Semin Cardiothorac Vasc Anesth 2018;22:150-63. [PMID: 29099334 DOI: 10.1177/1089253217739121] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
54 Chow JH, Lee K, Abuelkasem E, Udekwu OR, Tanaka KA. Coagulation Management During Liver Transplantation: Use of Fibrinogen Concentrate, Recombinant Activated Factor VII, Prothrombin Complex Concentrate, and Antifibrinolytics. Semin Cardiothorac Vasc Anesth 2018;22:164-73. [DOI: 10.1177/1089253217739689] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
55 McConnell M, Iwakiri Y. Biology of portal hypertension. Hepatol Int. 2018;12:11-23. [PMID: 29075990 DOI: 10.1007/s12072-017-9826-x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 8.2] [Reference Citation Analysis]
56 Tekola B, Caldwell S. Endoscopy in the Setting of Coagulation Abnormalities in the Patient with Liver Disease. Endoscopy in Liver Disease 2017. [DOI: 10.1002/9781118660799.ch3] [Reference Citation Analysis]
57 Vinholt PJ, Hvas AM, Nielsen C, Söderström AC, Sprogøe U, Fialla AD, Nybo M. Reduced platelet activation and platelet aggregation in patients with alcoholic liver cirrhosis. Platelets 2018;29:520-7. [PMID: 28895774 DOI: 10.1080/09537104.2017.1349308] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
58 Lisman T, Luyendyk JP. Platelets as Modulators of Liver Diseases. Semin Thromb Hemost 2018;44:114-25. [PMID: 28898899 DOI: 10.1055/s-0037-1604091] [Cited by in Crossref: 16] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
59 Lisman T, Porte RJ. Pathogenesis, prevention, and management of bleeding and thrombosis in patients with liver diseases. Res Pract Thromb Haemost 2017;1:150-61. [PMID: 30046685 DOI: 10.1002/rth2.12028] [Cited by in Crossref: 73] [Cited by in F6Publishing: 74] [Article Influence: 14.6] [Reference Citation Analysis]
60 Sarode R, Agrawal D, Cripps M, Kalva SP, Nagalla S. Re: Bleeding Risk and Management in Interventional Procedures in Chronic Liver Disease. J Vasc Interv Radiol 2017;28:921-2. [PMID: 28532751 DOI: 10.1016/j.jvir.2017.02.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
61 Lambert MP. Platelets in liver and renal disease. Hematology Am Soc Hematol Educ Program. 2016;2016:251-255. [PMID: 27913488 DOI: 10.1182/asheducation-2016.1.251] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 5.6] [Reference Citation Analysis]
62 Casari C, Bergmeier W. Acquired platelet disorders. Thromb Res 2016;141 Suppl 2:S73-5. [PMID: 27207431 DOI: 10.1016/S0049-3848(16)30371-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
63 Sinegre T, Lebreton A. Cirrhose et hémostase. Revue Francophone des Laboratoires 2017;2017:56-63. [DOI: 10.1016/s1773-035x(17)30079-5] [Reference Citation Analysis]
64 Thakrar SV, Mallett SV. Thrombocytopenia in cirrhosis: Impact of fibrinogen on bleeding risk. World J Hepatol 2017; 9(6): 318-325 [PMID: 28293381 DOI: 10.4254/wjh.v9.i6.318] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
65 Martini A, Ceranto E, Gatta A, Angeli P, Pontisso P. Occult liver disease burden: Analysis from a large general practitioners' database. United European Gastroenterol J 2017;5:982-6. [PMID: 29163964 DOI: 10.1177/2050640617696402] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
66 Abbas N, Makker J, Abbas H, Balar B. Perioperative Care of Patients With Liver Cirrhosis: A Review. Health Serv Insights 2017;10:1178632917691270. [PMID: 28469455 DOI: 10.1177/1178632917691270] [Cited by in Crossref: 26] [Cited by in F6Publishing: 32] [Article Influence: 5.2] [Reference Citation Analysis]
67 Lisman T, Porte RJ. Value of Preoperative Hemostasis Testing in Patients with Liver Disease for Perioperative Hemostatic Management. Anesthesiology 2017;126:338-44. [DOI: 10.1097/aln.0000000000001467] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 8.2] [Reference Citation Analysis]
68 Raparelli V, Basili S, Carnevale R, Napoleone L, Del Ben M, Nocella C, Bartimoccia S, Lucidi C, Talerico G, Riggio O, Violi F. Low-grade endotoxemia and platelet activation in cirrhosis. Hepatology 2017;65:571-81. [PMID: 27641757 DOI: 10.1002/hep.28853] [Cited by in Crossref: 74] [Cited by in F6Publishing: 79] [Article Influence: 14.8] [Reference Citation Analysis]
69 Seaman CD, Ragni MV. Coagulopathy in Cirrhosis. Surgical Procedures on the Cirrhotic Patient 2017. [DOI: 10.1007/978-3-319-52396-5_2] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
70 Lisman T. Hemostatic and Non-hemostatic Functions of Platelets in Patients with Liver Disease. Platelets in Thrombotic and Non-Thrombotic Disorders 2017. [DOI: 10.1007/978-3-319-47462-5_78] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
71 Tripodi A, Primignani M, Mannucci PM, Caldwell SH. Changing Concepts of Cirrhotic Coagulopathy. Am J Gastroenterol. 2017;112:274-281. [PMID: 27801884 DOI: 10.1038/ajg.2016.498] [Cited by in Crossref: 115] [Cited by in F6Publishing: 122] [Article Influence: 19.2] [Reference Citation Analysis]
72 Tsou YK, Liu CY, Fu KI, Lin CH, Lee MS, Su MY, Ohata K, Chiu CT. Endoscopic Submucosal Dissection of Superficial Esophageal Neoplasms Is Feasible and Not Riskier for Patients with Liver Cirrhosis. Dig Dis Sci 2016;61:3565-71. [PMID: 27770376 DOI: 10.1007/s10620-016-4342-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
73 Ambrosino P, Tarantino L, Di Minno G, Paternoster M, Graziano V, Petitto M, Nasto A, Di Minno MN. The risk of venous thromboembolism in patients with cirrhosis. A systematic review and meta-analysis. Thromb Haemost. 2017;117:139-148. [PMID: 27761574 DOI: 10.1160/th16-06-0450] [Cited by in Crossref: 105] [Cited by in F6Publishing: 108] [Article Influence: 17.5] [Reference Citation Analysis]
74 De Pietri L, Bianchini M, Rompianesi G, Bertellini E, Begliomini B. Thromboelastographic reference ranges for a cirrhotic patient population undergoing liver transplantation. World J Transplant 2016; 6(3): 583-593 [PMID: 27683637 DOI: 10.5500/wjt.v6.i3.583] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 32] [Article Influence: 5.0] [Reference Citation Analysis]
75 Maan R, de Knegt RJ, Veldt BJ. Management of Thrombocytopenia in Chronic Liver Disease: Focus on Pharmacotherapeutic Strategies. Drugs 2015;75:1981-92. [PMID: 26501978 DOI: 10.1007/s40265-015-0480-0] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 5.7] [Reference Citation Analysis]
76 DeAngelis GA, Khot R, Haskal ZJ, Maitland HS, Northup PG, Shah NL, Caldwell SH. Bleeding Risk and Management in Interventional Procedures in Chronic Liver Disease. J Vasc Interv Radiol 2016;27:1665-74. [PMID: 27595469 DOI: 10.1016/j.jvir.2016.05.039] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
77 Langness S, Costantini TW, Smith A, Bansal V, Coimbra R. Isolated traumatic brain injury in patients with cirrhosis: do different treatment paradigms result in increased mortality? Am J Surg 2017;213:80-6. [PMID: 27421188 DOI: 10.1016/j.amjsurg.2016.06.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
78 Andriulli A, Tripodi A, Angeli P, Senzolo M, Primignani M, Giannini EG, Riggio O, Colli A, Prati D, Sacerdoti D, Merkel C, Basili S, Ferro D, Villa E, Di Minno G, Caraceni P, Marzioni M, Mannucci PM, Violi F, Piscaglia F, Calvaruso V, De Pietri L, Falcone M, Feltracco P, Grandone E, La Mura V, Licata A, Lucidi C, Maimone S, Marietta M, Morisco F, Napoleone L, Piano S, Raparelli V, Rebulla P, Ribero D, Sartori MT, Scalera A, Schepis F, Siciliano M, Baroni GS, Tufano A, Vitale A, Zuin M. Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference. Digestive and Liver Disease 2016;48:455-67. [DOI: 10.1016/j.dld.2016.02.008] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 7.2] [Reference Citation Analysis]
79 La Mura V, Tripodi A, Tosetti G, Cavallaro F, Chantarangkul V, Colombo M, Primignani M. Resistance to thrombomodulin is associated with de novo portal vein thrombosis and low survival in patients with cirrhosis. Liver Int 2016;36:1322-30. [DOI: 10.1111/liv.13087] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 6.3] [Reference Citation Analysis]
80 Violi F, Corazza GR, Caldwell SH, Perticone F, Gatta A, Angelico M, Farcomeni A, Masotti M, Napoleone L, Vestri A, Raparelli V, Basili S; PRO-LIVER Collaborators. Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry. Intern Emerg Med. 2016;11:1059-1066. [PMID: 27026379 DOI: 10.1007/s11739-016-1416-8] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 9.8] [Reference Citation Analysis]
81 Magnusson M, Ignjatovic V, Hardikar W, Monagle P. A conceptual and practical approach to haemostasis in paediatric liver disease. Arch Dis Child. 2016;101:854-859. [PMID: 27013527 DOI: 10.1136/archdischild-2015-309535] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
82 Lopez-Delgado JC, Ballus J, Esteve F, Betancur-Zambrano NL, Corral-Velez V, Mañez R, Betbese AJ, Roncal JA, Javierre C. Outcomes of abdominal surgery in patients with liver cirrhosis. World J Gastroenterol 2016; 22(9): 2657-2667 [PMID: 26973406 DOI: 10.3748/wjg.v22.i9.2657] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 48] [Article Influence: 8.2] [Reference Citation Analysis]
83 Görlinger K, Sakai T, Dirkmann D, Planinsic RM, Saner FH. Bleeding Related to Liver Transplant. Management of Bleeding Patients 2016. [DOI: 10.1007/978-3-319-30726-8_29] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
84 Wilkey BJ, Hanson R, Reece TB, Forman L, Burton JR, Messenger JC, Kim MS, Cleveland JC, Fiegel MJ, Nydam TL, Mandell MS. Transfemoral Transcatheter Aortic Valve Replacement for Mixed Aortic Valve Disease in Child’s Class C Liver Disease Prior to Orthotopic Liver Transplantation: A Case Report. Semin Cardiothorac Vasc Anesth 2016;20:158-62. [DOI: 10.1177/1089253215619235] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
85 Biasiolo A, Trotta E, Fasolato S, Ruvoletto M, Martini A, Gallotta A, Fassina G, Angeli P, Gatta A, Pontisso P. Squamous cell carcinoma antigen-IgM is associated with hepatocellular carcinoma in patients with cirrhosis: A prospective study. Dig Liver Dis 2016;48:197-202. [PMID: 26614642 DOI: 10.1016/j.dld.2015.10.022] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
86 Baelum JK, Moe EE, Nybo M, Vinholt PJ. Venous Thromboembolism in Patients With Thrombocytopenia: Risk Factors, Treatment, and Outcome. Clin Appl Thromb Hemost 2017;23:345-50. [DOI: 10.1177/1076029615613158] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
87 Blasi A. Coagulopathy in liver disease: Lack of an assessment tool. World J Gastroenterol 2015; 21(35): 10062-10071 [PMID: 26401071 DOI: 10.3748/wjg.v21.i35.10062] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
88 Valla DC, Rautou PE. The coagulation system in patients with end-stage liver disease. Liver Int 2015;35 Suppl 1:139-44. [PMID: 25529099 DOI: 10.1111/liv.12723] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
89 Vucelic D. Diverse Utility of Endogenous Thrombin Potential and Thromboelastometry in the Assessment of Patients with Alcoholic Cirrhosis. HTIJ 2015;1. [DOI: 10.15406/htij.2015.01.00009] [Reference Citation Analysis]
90 Martí-Carvajal AJ, Solà I. Antifibrinolytic amino acids for upper gastrointestinal bleeding in people with acute or chronic liver disease. Cochrane Database Syst Rev 2015;:CD006007. [PMID: 26058965 DOI: 10.1002/14651858.CD006007.pub4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
91 Raparelli V, Basili S, Ferroni P. Platelet Function: the Janus face of haemostasis in cirrhosis. Thrombosis Research 2015;135:1224-5. [DOI: 10.1016/j.thromres.2015.04.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
92 Horsley-Silva JL, Vargas HE. Gastrointestinal endoscopy in the cirrhotic patient. Expert Rev Gastroenterol Hepatol. 2015;9:1005-1013. [PMID: 25967459 DOI: 10.1586/17474124.2015.1044978] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
93 Lopez-Delgado JC, Esteve F, Javierre C, Ventura JL, Mañez R, Farrero E, Torrado H, Rodríguez-Castro D, Carrio ML. Influence of cirrhosis in cardiac surgery outcomes. World J Hepatol 2015; 7(5): 753-760 [PMID: 25914775 DOI: 10.4254/wjh.v7.i5.753] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
94 Ogawa E, Furusyo N, Nakamuta M, Kajiwara E, Nomura H, Dohmen K, Takahashi K, Satoh T, Azuma K, Kawano A, Tanabe Y, Kotoh K, Shimoda S, Akahoshi T, Maehara Y, Hayashi J; Kyushu University Liver Disease Study (KULDS) Group. Efficacy and safety of splenectomy in telaprevir-based triple therapy for chronic hepatitis C patients with thrombocytopenia and advanced fibrosis. J Gastroenterol Hepatol 2014;29:1728-35. [PMID: 24731162 DOI: 10.1111/jgh.12619] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
95 Zanetto A, Senzolo M, Ferrarese A, Simioni P, Burra P, Rodríguez-castro KI. Assessment of Bleeding Risk in Patients with Cirrhosis. Curr Hepatology Rep 2015;14:9-18. [DOI: 10.1007/s11901-015-0250-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
96 Peck-Radosavljevic M, Angeli P, Cordoba J, Farges O, Valla D. Managing complications in cirrhotic patients. United European Gastroenterol J 2015;3:80-94. [PMID: 25653862 DOI: 10.1177/2050640614560452] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
97 Senzolo M, Burroughs A. Coagulopathy and clotting disorders. Cirrhosis: A practical guide to management 2015. [DOI: 10.1002/9781118412640.ch22] [Reference Citation Analysis]
98 Görlinger K, Schaden E, Saner FH. Perioperative Hemostasis in Hepatic Surgery. Perioperative Hemostasis 2015. [DOI: 10.1007/978-3-642-55004-1_15] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
99 Jairath V. Transfusion in Gastrointestinal Bleeding. Transfusion in the Intensive Care Unit 2015. [DOI: 10.1007/978-3-319-08735-1_12] [Reference Citation Analysis]
100 Chin JL, Hisamuddin SH, O'Sullivan A, Chan G, McCormick PA. Thrombocytopenia, Platelet Transfusion, and Outcome Following Liver Transplantation. Clin Appl Thromb Hemost 2016;22:351-60. [PMID: 25430936 DOI: 10.1177/1076029614559771] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
101 Alkozai EM, Porte RJ, Adelmeijer J, Zanetto A, Simioni P, Senzolo M, Lisman T. No evidence for increased platelet activation in patients with hepatitis B- or C-related cirrhosis and hepatocellular carcinoma. Thromb Res 2015;135:292-7. [PMID: 25434630 DOI: 10.1016/j.thromres.2014.11.016] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
102 Wannhoff A, Müller OJ, Friedrich K, Rupp C, Klöters-Plachky P, Leopold Y, Brune M, Senner M, Weiss KH, Stremmel W, Schemmer P, Katus HA, Gotthardt DN. Effects of increased von Willebrand factor levels on primary hemostasis in thrombocytopenic patients with liver cirrhosis. PLoS One 2014;9:e112583. [PMID: 25397410 DOI: 10.1371/journal.pone.0112583] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
103 Medeiros TB, Domingues AL, Luna CF, Lopes EP. Correlation between platelet count and both liver fibrosis and spleen diameter in patients with schistosomiasis mansoni. Arq Gastroenterol 2014;51:34-8. [PMID: 24760062 DOI: 10.1590/s0004-28032014000100008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
104 Boyer TD, Habib S. Big spleens and hypersplenism: fix it or forget it? Liver Int. 2015;35:1492-1498. [PMID: 25312770 DOI: 10.1111/liv.12702] [Cited by in Crossref: 35] [Cited by in F6Publishing: 41] [Article Influence: 4.4] [Reference Citation Analysis]
105 Terrault NA, Hassanein T, Howell CD, Joshi S, Lake J, Sher L, Vargas H, McIntosh J, Tang S, Jenkins TM. Phase II study of avatrombopag in thrombocytopenic patients with cirrhosis undergoing an elective procedure. J Hepatol. 2014;61:1253-1259. [PMID: 25048952 DOI: 10.1016/j.jhep.2014.07.007] [Cited by in Crossref: 56] [Cited by in F6Publishing: 60] [Article Influence: 7.0] [Reference Citation Analysis]
106 Sinegre T, Lebreton A. Hémostase et cirrhose. Revue Francophone des Laboratoires 2014;2014:65-72. [DOI: 10.1016/s1773-035x(14)72525-0] [Reference Citation Analysis]
107 Iacobellis A, Cozzolongo R, Minerva N, Valvano MR, Niro GA, Fontana R, Palmieri O, Ippolito A, Andriulli A. Feasibility of pegylated interferon and ribavirin in hepatitis C-related cirrhosis with neutropenia or thrombocytopenia. Dig Liver Dis 2014;46:621-4. [PMID: 24675038 DOI: 10.1016/j.dld.2014.02.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
108 Lemoinne S, Thabut D, Housset C, Moreau R, Valla D, Boulanger CM, Rautou PE. The emerging roles of microvesicles in liver diseases. Nat Rev Gastroenterol Hepatol. 2014;11:350-361. [PMID: 24492276 DOI: 10.1038/nrgastro.2014.7] [Cited by in Crossref: 121] [Cited by in F6Publishing: 175] [Article Influence: 15.1] [Reference Citation Analysis]
109 Tripodi A, Primignani M. Nontransfusional approach to increased platelet count in patients with cirrhosis and thrombocytopenia. Hepatology 2013;58:1177-80. [PMID: 23703879 DOI: 10.1002/hep.26502] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
110 Tapper EB, Robson SC, Malik R. Coagulopathy in cirrhosis - the role of the platelet in hemostasis. J Hepatol. 2013;59:889-890. [PMID: 23669288 DOI: 10.1016/j.jhep.2013.03.040] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
111 Mallett SV, Chowdary P, Burroughs AK. Clinical utility of viscoelastic tests of coagulation in patients with liver disease. Liver Int. 2013;33:961-974. [PMID: 23638693 DOI: 10.1111/liv.12158] [Cited by in Crossref: 65] [Cited by in F6Publishing: 72] [Article Influence: 7.2] [Reference Citation Analysis]
112 Agarwal A, Sharma N, Vij V. Point-of-care coagulation monitoring during liver transplantation. Trends in Anaesthesia and Critical Care 2013;3:42-8. [DOI: 10.1016/j.tacc.2012.12.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
113 Lisman T, Porte RJ. Understanding and Managing the Coagulopathy of Liver Disease. Consultative Hemostasis and Thrombosis 2013. [DOI: 10.1016/b978-1-4557-2296-9.00038-5] [Reference Citation Analysis]
114 Chamorro López L, Martínez González J, García Cano AM, Busto Durán R, Albillos Martínez A, Pastor Rojo Ó. Análisis de la composición de ácido araquidónico y ácidos grasos omega-3 en plasma, membrana eritrocitaria y células inmunitarias de pacientes con cirrosis. Revista del Laboratorio Clínico 2013;6:10-17. [DOI: 10.1016/j.labcli.2012.05.004] [Reference Citation Analysis]
115 Johanning K. Intraoperatives Gerinnungsmanagement. Visc Med 2013;29:280-288. [DOI: 10.1159/000355382] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
116 Tripodi A, Primignani M, Chantarangkul V, Lemma L, Jovani M, Rebulla P, Mannucci PM. Global hemostasis tests in patients with cirrhosis before and after prophylactic platelet transfusion. Liver Int. 2013;33:362-367. [PMID: 23231699 DOI: 10.1111/liv.12038] [Cited by in Crossref: 83] [Cited by in F6Publishing: 90] [Article Influence: 8.3] [Reference Citation Analysis]
117 Mannucci PM, Tripodi A. Hemostatic defects in liver and renal dysfunction. Hematology 2012;2012:168-73. [DOI: 10.1182/asheducation.v2012.1.168.3798232] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 3.6] [Reference Citation Analysis]
118 Mannucci PM, Tripodi A. Liver disease, coagulopathies and transfusion therapy. Blood Transfus. 2013;11:32-36. [PMID: 23058863 DOI: 10.2450/2012.0151-12] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
119 Martí-Carvajal AJ, Solà I, Martí-Carvajal PI. Antifibrinolytic amino acids for upper gastrointestinal bleeding in patients with acute or chronic liver disease. Cochrane Database Syst Rev 2012;:CD006007. [PMID: 22972089 DOI: 10.1002/14651858.CD006007.pub3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
120 Lisman T, Porte RJ. Platelet function in patients with cirrhosis. J Hepatol 2012;56:993-4; author reply 994-5. [PMID: 22424439 DOI: 10.1016/j.jhep.2011.08.013] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
121 Basili S, Raparelli V, Pignatelli P, Violi F. Pitfalls in assessing platelet activation status in patients with liver disease: authors’ reply. Liver Int 2012;32:1028-1028. [DOI: 10.1111/j.1478-3231.2012.02808.x] [Reference Citation Analysis]
122 Caldwell S, Intagliata N. Dismantling the myth of "autoanticoagulation" in cirrhosis: an old dogma dies hard. Hepatology 2012;55:1634-7. [PMID: 22517550 DOI: 10.1002/hep.25623] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
123 Basili S, Raparelli V, Pignatelli P, Violi F. “Pitfalls in assessing platelet activation status in patients with liver disease: authors’ reply”. Liver Int 2012. [DOI: 10.1111/j.1478-3231.2012.02760.x] [Reference Citation Analysis]
124 Alkim H, Ayaz S, Sasmaz N, Oguz P, Sahin B. Hemostatic Abnormalities in Cirrhosis and Tumor-Related Portal Vein Thrombosis. Clin Appl Thromb Hemost 2012;18:409-15. [DOI: 10.1177/1076029611427900] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
125 Ferro D, Angelico F, Caldwell SH, Violi F. Bleeding and thrombosis in cirrhotic patients: what really matters? Dig Liver Dis. 2012;44:275-279. [PMID: 22119620 DOI: 10.1016/j.dld.2011.10.016] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]